| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Talaris Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 20,500 | 13 Jun 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| TRML | Talaris Therapeutics, Inc. | 13 Jun 2023 | 1 | $0 | 4 | Director | 14 Jun 2023, 18:56 |
| TRML | Talaris Therapeutics, Inc. | 09 Jun 2022 | 1 | $0 | 4 | Director, 10%+ Owner | 13 Jun 2022, 18:13 |
| TRML | Talaris Therapeutics, Inc. | 11 May 2021 | 5 | +$3,995,000 | 4 | Director, 10%+ Owner | 11 May 2021, 20:29 |